It's probably worth to clarify that out of the 60 patients, 15 were injected with 25M and the other 15 were inject with 75M of Revascor. One of things I don't like about this study was the skew of population of class II and class III in the 150M treated and control groups
"The 150m treated patients in the phase 2 trial were mostly Class II (12 or 80%) and Class III (3 or 20%) vs Control of Class II (6 of 40%) and Class III (9 60%). This means the likelihood of HF-MACE events was inherently higher in the control vs 150m dose treated patients"
- Forums
- ASX - By Stock
- MSB
- Phase 3 DREAM HF-1 read-out
Phase 3 DREAM HF-1 read-out, page-28
-
- There are more pages in this discussion • 317 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B |
Open | High | Low | Value | Volume |
$1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 3875 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | 1.055 |
9 | 193430 | 1.050 |
3 | 44331 | 1.045 |
5 | 117942 | 1.040 |
3 | 53830 | 1.035 |
Price($) | Vol. | No. |
---|---|---|
1.065 | 3875 | 2 |
1.070 | 28953 | 3 |
1.075 | 46564 | 3 |
1.080 | 87551 | 5 |
1.085 | 47614 | 4 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |